Clinical Trials in Denver

Showing 11581-11600 of 18,161 trials

MRI to Detect Breast Tumors in Women

NCT00003302

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Breast Cancer

Abramson Cancer Center at Penn Medicine1,500 participantsStarted May 1998

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

NCT01168973

The purpose of the study is to compare the survival of participants who receive chemotherapy and ramucirumab versus chemotherapy alone as second line treatment for NSCLC after prior first line platinum-based chemotherapy.

Non-Small Cell Lung Cancer

Eli Lilly and Company1,253 participantsStarted Dec 2010

Phoenix, Arizona, United States • Sedona, Arizona, United States • Fayetteville, Arkansas, United States +228 more locations

MRI to Detect Breast Tumors in Women

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Find Trials by Condition in Denver

A Study in Second Line Metastatic Colorectal Cancer

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

Study of Ramucirumab in Ovarian Cancer

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

A Study in Advanced Solid Tumors

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear